Pfizer Earnings Before Interest Taxes and Depreciation Amortization EBITDA Trend from 2010 to 2022

PFE
 Stock
  

USD 50.11  1.82  3.77%   

Pfizer Earnings Before Interest Taxes and Depreciation Amortization EBITDA are increasing over the years with slightly volatile fluctuation. Earnings Before Interest Taxes and Depreciation Amortization EBITDA are expected to dwindle to about 23.1 B. During the period from 2010 to 2022 Pfizer Earnings Before Interest Taxes and Depreciation Amortization EBITDA anual values regression line had geometric mean of 18,180,212,132 and significance of  0.24. Pfizer Cost of Revenue is projected to decrease significantly based on the last few years of reporting. The past year's Cost of Revenue was at 9.2 Billion. The current year Gross Profit is expected to grow to about 37.7 B, whereas Earning Before Interest and Taxes EBIT is forecasted to decline to about 18.5 B.
  
Check Pfizer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pfizer main balance sheet or income statement drivers, such as Direct Expenses of 33.3 B, Consolidated Income of 17 B or Cost of Revenue of 9.4 B, as well as many exotic indicators such as Interest Coverage of 15.54, Long Term Debt to Equity of 0.45 or Calculated Tax Rate of 9.19. Pfizer financial statements analysis is a perfect complement when working with Pfizer Valuation or Volatility modules. It can also supplement Pfizer's financial leverage analysis and stock options assessment as well as various Pfizer Technical models . Please check the analysis of Pfizer Correlation against competitors.

Pfizer Earnings Before Interest Taxes and Depreciation Amortization EBITDA Breakdown

Showing smoothed Earnings Before Interest Taxes and Depreciation Amortization EBITDA of Pfizer Inc with missing and latest data points interpolated. EBITDA is a non-GAAP accounting metric that is widely used when assessing the performance of companies; calculated by adding Depreciation Amortization and Accretion back to Earning Before Interest and Taxes EBIT.Pfizer's Earnings Before Interest Taxes and Depreciation Amortization EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pfizer's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 43.06 B10 Years Trend
Increasing
Slightly volatile
   Earnings Before Interest Taxes and Depreciation Amortization EBITDA   
Share
       Timeline  

Pfizer Earnings Before Interest Taxes and Depreciation Amortization EBITDA Regression Statistics

Arithmetic Mean 18,716,935,223
Geometric Mean 18,180,212,132
Coefficient Of Variation 25.48
Mean Deviation 3,591,766,428
Median 17,942,000,000
Standard Deviation 4,769,857,792
Range 16,957,000,000
R-Value 0.35
R-Squared 0.12
Significance 0.24
Slope 429,263,447

Pfizer Earnings Before Interest Taxes and Depreciation Amortization EBITDA History

201218.4 B
201321.3 B
201417.2 B
201513.4 B
201613.1 B
201717.9 B
201817.8 B
201923.6 B
202012.3 B
202129.3 B
202223.1 B

About Pfizer Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Pfizer income statement, its balance sheet, and the statement of cash flows. Pfizer investors use historical funamental indicators, such as Pfizer's Earnings Before Interest Taxes and Depreciation Amortization EBITDA, to determine how well the company is positioned to perform in the future. Although Pfizer investors may use each financial statement separately, they are all related. The changes in Pfizer's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pfizer's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pfizer Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pfizer. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Earnings Before Interest Taxes and Depreciation Amortization EBITDA29.3 B23.1 B
Earnings before Tax20.3 B18.5 B
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people.

Pfizer Investors Sentiment

The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Pfizer's public news can be used to forecast risks associated with investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pfizer's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Pfizer.

Pfizer Implied Volatility

    
  25.12  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.

Currently Active Assets on Macroaxis

Please check the analysis of Pfizer Correlation against competitors. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.77
Market Capitalization
281.2 B
Quarterly Revenue Growth YOY
0.47
Return On Assets
0.13
Return On Equity
0.37
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.